---
figid: PMC6632210__12917_2019_1997_Fig7_HTML
figlink: /pmc/articles/PMC6632210/figure/Fig7/
number: Fig. 7
caption: Schematic diagram of LPS-mediated platelet activation and TLR4 expression
  in canine platelets. ADP activation via P2Y1 or P2Y12 receptor upregulates surface
  TLR4 expression. TLR4 trafficking to cell membrane from granules may be mediated
  by alpha-granule secretion. LPS binding protein (LBP) presents LPS to CD14 forming
  a heterodimeric complex with TLR4 and myeloid differentiation protein 2 (MD-2).
  Downstream signaling pathway of TLR4 leads to α-granule secretion, which is amplified
  by ADP and thromboxane A2 (TxA2). Activation of G-protein coupled receptors, P2Y1/P2Y12
  and thromboxane receptor (TP), leads to phospholipase C (PLC) activation and, subsequently,
  1,4,5-triphosphate (IP3) and diacylglycerol (DAG) for intracellular calcium release
  and alpha-granule secretion. LPS acts synergistically with ADP to increase generation
  of TxA2, serving a positive feedback mediator. TLR4 and ADP signaling activates
  cyclooxygenase-1 (COX-1), which converts arachidonic acid (AA) to TxA2, likely by
  the Akt/p38 MAPK pathway
pmcid: PMC6632210
papertitle: 'Canine platelets express functional Toll-like receptor-4: lipopolysaccharide-triggered
  platelet activation is dependent on adenosine diphosphate and thromboxane A2 in
  dogs.'
reftext: Ronald H. L. Li, et al. BMC Vet Res. 2019;15:245.
pmc_ranked_result_index: '128723'
pathway_score: 0.9696851
filename: 12917_2019_1997_Fig7_HTML.jpg
figtitle: LPS-mediated platelet activation and TLR4 expression in canine platelets
year: '2019'
organisms: Homo sapiens
ndex: a8758bf7-dec9-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6632210__12917_2019_1997_Fig7_HTML.html
  '@type': Dataset
  description: Schematic diagram of LPS-mediated platelet activation and TLR4 expression
    in canine platelets. ADP activation via P2Y1 or P2Y12 receptor upregulates surface
    TLR4 expression. TLR4 trafficking to cell membrane from granules may be mediated
    by alpha-granule secretion. LPS binding protein (LBP) presents LPS to CD14 forming
    a heterodimeric complex with TLR4 and myeloid differentiation protein 2 (MD-2).
    Downstream signaling pathway of TLR4 leads to α-granule secretion, which is amplified
    by ADP and thromboxane A2 (TxA2). Activation of G-protein coupled receptors, P2Y1/P2Y12
    and thromboxane receptor (TP), leads to phospholipase C (PLC) activation and,
    subsequently, 1,4,5-triphosphate (IP3) and diacylglycerol (DAG) for intracellular
    calcium release and alpha-granule secretion. LPS acts synergistically with ADP
    to increase generation of TxA2, serving a positive feedback mediator. TLR4 and
    ADP signaling activates cyclooxygenase-1 (COX-1), which converts arachidonic acid
    (AA) to TxA2, likely by the Akt/p38 MAPK pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD14
  - LBP
  - AKT2
  - PLCB1
  - CS
  - PLCB2
  - IRF6
  - PLCB4
  - PLCE1
  - P2RY1
  - PLCB3
  - MAPK14
  - LY96
  - TLR4
  - P2RY12
  - WDTC1
  - AKT3
  - AKT1
  - PLCG1
  - PLCG2
  - PLCD4
  - PLCD1
  - PLCD3
  - MAPK11
  - MAPK13
  - PLCZ1
  - MAPK12
  - TXA2
  - ADP
  - Ca++
  - LPS
genes:
- word: CD14?
  symbol: CD14
  source: hgnc_symbol
  hgnc_symbol: CD14
  entrez: '929'
- word: LBP
  symbol: LBP
  source: hgnc_symbol
  hgnc_symbol: LBP
  entrez: '3929'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB1
  entrez: '23236'
- word: CS
  symbol: CS
  source: hgnc_symbol
  hgnc_symbol: CS
  entrez: '1431'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB2
  entrez: '5330'
- word: LPS
  symbol: LPS
  source: hgnc_prev_symbol
  hgnc_symbol: IRF6
  entrez: '3664'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB4
  entrez: '5332'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCE1
  entrez: '51196'
- word: P2Y1/
  symbol: P2Y1
  source: hgnc_alias_symbol
  hgnc_symbol: P2RY1
  entrez: '5028'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB3
  entrez: '5331'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MD2
  symbol: MD-2
  source: hgnc_alias_symbol
  hgnc_symbol: LY96
  entrez: '23643'
- word: TLR4
  symbol: TLR4
  source: hgnc_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: P2Y12
  symbol: P2Y12
  source: hgnc_alias_symbol
  hgnc_symbol: P2RY12
  entrez: '64805'
- word: ADP
  symbol: ADP
  source: hgnc_alias_symbol
  hgnc_symbol: WDTC1
  entrez: '23038'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD4
  entrez: '84812'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD1
  entrez: '5333'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD3
  entrez: '113026'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCZ1
  entrez: '89869'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
chemicals:
- word: TXA2
  source: MESH
  identifier: D014148
- word: ADP
  source: MESH
  identifier: D000244
- word: Ca++
  source: MESH
  identifier: D002118
diseases:
- word: LPS
  source: MESH
  identifier: C536528
---
